| NDC Code | 70842-225-01 |
|---|
| Package Description | 1 VIAL in 1 CARTON (70842-225-01) / 40 mL in 1 VIAL |
|---|
| Product NDC | 70842-225 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Kimyrsa |
|---|
| Non-Proprietary Name | Oritavancin Diphosphate |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20210323 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA214155 |
|---|
| Manufacturer | Melinta Therapeutics, LLC |
|---|
| Substance Name | ORITAVANCIN DIPHOSPHATE |
|---|
| Strength | 1200 |
|---|
| Strength Unit | mg/40mL |
|---|
| Pharmacy Classes | Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS] |
|---|